REGULATORY INTELLIGENCE·Recall
Owen Biosciences Faces FDA Class II Recall for Benzene Contamination in Benzoyl Peroxide Acne Treatment
Owen Biosciences Inc. has initiated a nationwide Class II recall for its 2.5% Benzoyl Peroxide Acne Treatment due to benzene contamination. This event highlights critical quality control deficiencies in OTC drug manufacturing. Procurement directors and regulatory affairs heads must reassess supplier vetting and product testing protocols to mitigate significant supply chain and reputational risks.
90-Day Activity